Drug Trial Radar · NCT06760637
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,037
Actual
Start
Jan 6, 2025
Primary completion
Jan 2, 2029
Study completion Dec 29, 2037
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Jan 7, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the safety and efficacy of PF-07220060 with letrozole compared to approved treatments (ie, palbociclib, ribociclib or abemaciclib with letrozole) in people with breast cancer: * HR-positive (breast cancer cells that need estrogen or progesterone to grow) * HER2-negative (cells that have a small amount or none of a protein called HER2 on their surface); * locally advanced (that has spread from where it started to nearby tissue or lymph nodes) or metastatic disease (the spread of cancer to other places in the body) * who have not received any prior systemic anti-cancer treatment for advanced/metastatic disease. Approximately half of the participants will receive PF-07220060 plus letrozole while the other half of participants will receive the investigator's choice of treatment plus letrozole. The study team will monitor how each participant is doing with the study treatment during regular visits at the study clinic.
Conditions
- Breast Cancer
Interventions
PF-07220060Drug
CDK4 inhibitor
letrozoleDrug
endocrine therapy
abemaciclibDrug
CDK4/6 inhibitor
palbociclibDrug
CDK4/6 inhibitor
ribociclibDrug
CDK4/6 inhibitor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression Free Survival (PFS) by BICRTime frame: From the date of randomization until disease progression or death due to any cause (up to approximately 4 years)
Locations
460 sites in 30 countries. Site status is shown where the registry gives one.
Infusion Therapy Extended Care Clinic (ECC)
Birmingham, Alabama
The Kirklin Clinic of UAB Hospital
Birmingham, Alabama
The University of Alabama at Birmingham
Birmingham, Alabama
Ironwood Cancer & Research Centers
Chandler, Arizona
Ironwood Cancer & Research Centers
Gilbert, Arizona
Ironwood Cancer & Research Centers
Glendale, Arizona
Ironwood Cancer & Research Centers
Goodyear, Arizona
Ironwood Cancer & Research Centers
Mesa, Arizona
Ironwood Cancer & Research Centers
Mesa, Arizona
Ironwood Cancer & Research Centers
Phoenix, Arizona
Ironwood Cancer & Research Centers
Scottsdale, Arizona
CARTI Cancer Center Saline County
Bryant, Arkansas
CARTI Cancer Center Conway
Conway, Arkansas
Highlands Oncology Group, PA
Fayetteville, Arkansas
CARTI Cancer Center
Little Rock, Arkansas
CARTI Cancer Center North Little Rock Urology
North Little Rock, Arkansas
CARTI Cancer Center North Little Rock
North Little Rock, Arkansas
CARTI Cancer Center Pine Bluff
Pine Bluff, Arkansas
Highlands Oncology Group, PA
Rogers, Arkansas
Highlands Oncology Group, PA
Springdale, Arkansas
Sutter Auburn Faith Hospital
Auburn, California
Sutter Health Alta Bates
Berkeley, California
Cedars-Sinai Cancer Beverly Hills (drug treatment and dispensing location)
Beverly Hills, California
Cedars-Sinai Cancer Beverly Hills
Beverly Hills, California
Marshall Cancer Center
Cameron Park, California
Enloe Medical Center
Chico, California
Enloe Regional Cancer Center
Chico, California
City of Hope Investigational Drug Service (IDS)
Duarte, California
City of Hope(City of Hope National Medical Center,City of Hope Medical Center)
Duarte, California
UCSF Washington Hospital Cancer Center/ Washington Hospital Healthcare System
Fremont, California
Premier Cancer Care and Infusion Center - Fresno - North Thesta Street
Fresno, California
Providence Medical Foundation
Fullerton, California
Providence St. Jude Medical Center Virginia K Crosson Cancer Center & Infusion Center
Fullerton, California
City of Hope - Seacliff
Huntington Beach, California
City of Hope at Irvine Lennar
Irvine, California
City of Hope Investigational Drug Service (IDS)
Irvine, California
Hoag Health Center Irvine
Irvine, California
Hoag Hospital Irvine
Irvine, California
City of Hope-Antelope Valley
Lancaster, California
City of Hope at Long Beach Elm
Long Beach, California
Showing 40 of 460 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.